EUVIMEDEUVIMED entdecken
Open Access

Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy

Enrico Caliman, Sara Fancelli, Federico Scolari, Adriano Pasqui, Clara Manneschi, Daniele Lavacchi, Francesca Mazzoni, Francesca Gensini, Valeria Pasini, Camilla Eva Comin, Luca Voltolini, Serena Pillozzi und 1 weitere

Oncology Research · 2025

DOI: 10.32604/or.2024.050161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Enrico Caliman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Endonucleases, DNA-Binding Proteins, Xeroderma Pigmentosum Group D Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideEndonucleasesDNA-Binding ProteinsXeroderma Pigmentosum Group D ProteinSmall Cell Lung CarcinomaLung NeoplasmsHumansFemaleMaleMiddle AgedAgedPrognosisRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and overPlatinumDNA RepairAdultBiomarkers, TumorNuclear ProteinsTranscription FactorsDNA Excision Repair Protein ERCC-5

Stichwörter der Autor:innen

ERCC genesNucleotide excision repair (NER) pathwayPlatinum-chemotherapy (CT)Single nucleotide polymorphisms (SNPs)Small cell lung cancer (SCLC)

Substanzen

EndonucleasesDNA-Binding ProteinsXeroderma Pigmentosum Group D ProteinPlatinumBiomarkers, TumorNuclear ProteinsTranscription FactorsDNA Excision Repair Protein ERCC-5ERCC1 protein, humanERCC2 protein, human

Autor:innen und Institutionen

  • Clinical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy.
  • Department of Health Sciences, University of Florence, Florence, 50134, Italy.
  • Medical Oncology Unit, Careggi University Hospital, Florence, 50134, Italy.
  • Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50134, Italy.
  • Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, 50139, Italy.

Zitieren

APA

Caliman, E., Fancelli, S., Scolari, F., Pasqui, A., Manneschi, C., Lavacchi, D., Mazzoni, F., Gensini, F., Pasini, V., Comin, C. E., Voltolini, L., Pillozzi, S., & Antonuzzo, L. (2025). Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. Oncology Research. https://doi.org/10.32604/or.2024.050161

Vancouver

Caliman E, Fancelli S, Scolari F, Pasqui A, Manneschi C, Lavacchi D, et al. Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. Oncology Research. 2025. doi:10.32604/or.2024.050161

BibTeX
@article{Caliman2025,
  author = {Caliman, Enrico and Fancelli, Sara and Scolari, Federico and Pasqui, Adriano and Manneschi, Clara and Lavacchi, Daniele and Mazzoni, Francesca and Gensini, Francesca and Pasini, Valeria and Comin, Camilla Eva and Voltolini, Luca and Pillozzi, Serena and Antonuzzo, Lorenzo},
  title = {Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.050161}
}
Kostenlos starten →